No doubt 2025 will usher in many more advances in CRISPR therapies, thanks to the FDA’s new Platform Technology Designation ...

Autophagy is the process by which cells digest and renew their internal structures, recycling damaged or malfunctioning ...

Africa is grappling with severe food insecurity in the wake of consecutive droughts, climate change, and ongoing conflicts, which are affecting millions across the continent.

The CRISPR/Cas9 gene editing technology uses a human engineered guide RNA to lead an enzyme called Cas9 to a specific region of DNA. Cas9 acts like a pair of “molecular scissors” and cuts the DNA.

CRISPR Therapeutics (NASDAQ:CRSP – Get Free Report) had its price target hoisted by Barclays from $55.00 to $56.00 in a note ...

CRISPR Therapeutics (NASDAQ:CRSP – Get Free Report) had its price target hoisted by equities researchers at Truist Financial from $100.00 to $120.00 in a report issued on Wednesday,Benzinga reports.

CRISPR technology has radically transformed genetic research, and at the forefront of this transformation is CRISPR screening ...

Crispr Therapeutics AG has revenue declines but holds strong financials. Promising Sickle Cell therapy & 2025 data readouts ...

Biotechnology is a rapidly evolving sector with significant advancements anticipated between 2025 and 2035. As innovations in ...

For many years, cloned ponies have excelled in the prestigious equestrian sport of polo, and the sport has now taken a ...

Gene editing is already being used to treat a handful of rare genetic diseases; however, most therapies involve breaking or ...